your market intelligence analyst
Search Results
Edit Save
547 results
The malaria drug hydroxychloroquine, which has been promoted as a potential treatment for COVID-19, is known to have potentially serious effects on heart rhythms. Now, a team of researchers has used an optical mapping system to observe exactly how the drug creates serious disturbances in the electrical signals that govern heartbeat.
Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease. Finding drugs that can inhibit the infection caused by SARS-CoV-2 is an essential step to finding the vaccine that can definitively bring the spread of the virus to an end.
Every year there are ten million new cases of cancer in the world and the World Health Organisation estimates that the number of annual deaths associated with this disease will reach 13 million by the year 2030. There are various treatments for cancer but in many cases they cause toxicity in some patients or lead to the development of resistance in others. This has led in recent years to an increase in the use of bioactive compounds (BAC) such as polyphenols and flavonoids in these medical treatments because of their proven anti-carcinogenic properties based on their antioxidant, anti-inflammatory and immune-modulating components.
The biggest pharmaceutical companies in the world, known as "big pharma", are American and European. The top five are Pfizer (US), Roche, Novartis (both Swiss), Merck (US) and GlaxoSmithKline (UK). Yet these companies—and the pharmaceutical industry as a whole—rely on global supply chains. And China and India play key roles in the supply of both ingredients and finished drugs.
The coronavirus has the world in its grip. Finding a cure has never been more important. Unfortunately, the development of new drugs for treatment of the COVID-19 disease caused by the virus and development of a vaccine are complex, lengthy, and above all costly processes. With the help of computer models, this can be accelerated. Researchers at the Center for Computational Life Sciences (CCLS) are researching these models in order to reduce costs and speed up the process of drug development.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications